CHRISTOPHER MCGREW: Open Payments
NPI 1821309097 · NORTHVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 23 payments from 9 companies in 2025. Trend: 2023 $1,025 · 2024 $1,444 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $142 |
| PFIZER INC. | 4 | $69 |
| ABBVIE INC. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Exact Sciences Corporation | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, VRAYLAR, Cologuard Collection Kit, AUSTEDO XR, Ozempic, LEQVIO, REXULTI, FARXIGA.
Industry payments across MI — which companies pay providers there.
